Two Sigma Investments’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
Other funds holding DRUG
Two Sigma Investments's DRUG Position: Q3 2026 in Review
Two Sigma Investments sold out of Bright Minds Biosciences (DRUG) in Q3 2026, closing a stake of 9,606 shares — an estimated $674K sold.
Two Sigma Investments first reported a position in DRUG in Q3 2022 and held it in 4 quarters. The position peaked at $674K in Q2 2026. 110 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.
- Two Sigma Investments reported no remaining Bright Minds Biosciences position as of Q3 2026 after selling out during the quarter.
- Two Sigma Investments sold 9,606 Bright Minds Biosciences shares in Q3 2026, an estimated $674K.
- Two Sigma Investments first reported a position in Bright Minds Biosciences in Q3 2022 and held it in 4 quarters.
- Two Sigma Investments's Bright Minds Biosciences position peaked at $674K in Q2 2026.
- 110 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.